SLC38A2 and non-small cell lung carcinoma: Furthermore, SLC38A2 was the only glutamine transporter significantly elevated in SCCOHT patient tumors compared to HGSOCs (Supplementary Fig. 6c); this was also observed in NSCLC tumors expressing lower levels of SMARCA4/2 (Supplementary Fig. 6d, e).